AGIRX LTD has a total of 18 patent applications. Its first patent ever was published in 2004. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals and biotechnology are ANTICANCER THERAPEUTIC INV SA, CONARIS RES INST AG and MILKHAUS LAB INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 3 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | Israel | 2 | |
#7 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Mackiewicz Andrzej | 12 |
#2 | Dams-Kozlowska Hanna | 4 |
#3 | Rose-John Stefan | 4 |
#4 | Wysocki Piotr | 2 |
#5 | Andrzej Mackiewicz | 2 |
#6 | Suchorska Wiktoria | 2 |
#7 | Wiktoria Suchorska | 1 |
#8 | Mackiewicz Andrzej Prof | 1 |
#9 | Stefan Mackiewicz Andrzej Dams | 1 |
#10 | Dams-Kozlowska Hanna Dr | 1 |
Publication | Filing date | Title |
---|---|---|
WO2010081738A1 | Vaccine compositions | |
WO2009095033A1 | Vaccine compositons | |
EP1598364A1 | Chimerical soluble hyper IL-11 receptor and use thereof |